Streptozotocin in the treatment of cancer: phase II study
- PMID: 4261143
- DOI: 10.1002/1097-0142(197207)30:1<61::aid-cncr2820300110>3.0.co;2-o
Streptozotocin in the treatment of cancer: phase II study
Similar articles
-
Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer.Eur J Cancer (1965). 1981 Mar;17(3):337-43. doi: 10.1016/0014-2964(81)90125-0. Eur J Cancer (1965). 1981. PMID: 6455296 No abstract available.
-
Streptozotocin therapy in 22 cancer patients.Cancer. 1975 Feb;35(2):358-67. doi: 10.1002/1097-0142(197502)35:2<358::aid-cncr2820350210>3.0.co;2-g. Cancer. 1975. PMID: 122912
-
Phase II study of hexamethylmelamine (NSC 13875).Cancer. 1969 Jan;23(1):132-6. doi: 10.1002/1097-0142(196901)23:1<132::aid-cncr2820230116>3.0.co;2-7. Cancer. 1969. PMID: 5812585 No abstract available.
-
[Preventive and therapeutic measures in cytostatic-associated toxicity].Schweiz Med Wochenschr. 1990 Sep 15;120(37):1353-62. Schweiz Med Wochenschr. 1990. PMID: 2218458 Review. German.
-
[Prevention and treatment of complications caused by the use of antibiotics (literature survey)].Vrach Delo. 1974;0(7):13-8. Vrach Delo. 1974. PMID: 4609356 Review. Russian. No abstract available.
Cited by
-
Chemotherapy for the carcinoid syndrome.Cancer Chemother Pharmacol. 1981;5(3):133-8. doi: 10.1007/BF00258469. Cancer Chemother Pharmacol. 1981. PMID: 7296750
-
N-methyl antitumour agents. A distinct class of anticancer drugs?Cancer Chemother Pharmacol. 1987;19(2):91-102. doi: 10.1007/BF00254559. Cancer Chemother Pharmacol. 1987. PMID: 3552281 Review.